Opus Genetics, Inc. (IRD) support and resistance · rev $11.0M
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
This page maps Opus Genetics, Inc. (IRD) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
IRD currently screens at market cap $35.7M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new IRD 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the IRD quote page for the session range and the stock page for the full model.
Not investment advice.